Nantahala Capital Management - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$10,117,146
-15.5%
1,732,388
-3.1%
0.66%
-15.4%
Q3 2022$11,974,000
+71.4%
1,787,159
+7.7%
0.78%
+121.4%
Q2 2022$6,988,0001,659,8400.35%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CONCERT PHARMACEUTICALS INC shareholders